Table 1.

Participant characteristics

Characteristic	Atogepant 170 mg q.d. (n = 23)	Placebo q.d. (n = 11)
Age, mean (SD) [range], years	37.1 (9.5) [23–55]	39.8 (9.3) [25–55]
Sex, male, n (%)	19 (82.6)	8 (72.7)
Race, n (%)
Black/African American	13 (56.5)	5 (45.5)
White	9 (39.1)	6 (54.5)
Multiple	1 (4.3)	0
Ethnicity, n (%)
Hispanic or Latino	0	1 (9.1)